Masahiro Fukuoka

Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.

M. Fukuoka, M. Takada, K. Nakagawa, 1994, British Journal of Cancer.

Point mutations of the topoisomerase IIalpha gene in patients with small cell lung cancer treated with etoposide.

M. Fukuoka, A. Kubo, J. Takahara, 1996, Cancer research.

Endpoints for multimodal clinical trials in stage III non-small cell lung cancer (NSCLC): a consensus report.

R. Arriagada, M. Fukuoka, J. Cox, 1994, Lung cancer.

Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for EGFR mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01).

A. Tsuya, Hiromasa Harada, K. Otani, 2023, Japanese journal of clinical oncology.

Feasibility Study of Nivolumab in Combination with Carboplatin Plus Paclitaxel and Concurrent Thoracic Radiation in Patients with Untreated Unresectable Locally Advanced Non-Small Cell Lung Cancer

M. Terashima, Y. Takeyasu, Y. Yamanaka, 2024, Cancers.